Find the latest and updated news related to Quetiapine Hemifumarate aggregated by PharmaCompass.com.

Quetiapine Hemifumarate
News
Full Screen View

Quetiapine Hemifumarate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

107 Suppliers, 57 USDMF, 37 CEP/COS, 9 JDMF, 36 EU WC, 33 KDMF, 34 NDC API, 64 Listed Suppliers

DEVELOPMENTS

13 Drug(s) in Development

13 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

31 Suppliers

31 Suppliers

DOSSIERs // Finished Dosage Forms

1260 Dossiers, 192 FDA Orange Book, 609 Europe, 148 Canada, 58 Australia, 110 South Africa, 143 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 300MG BASE, TABLET;ORAL - EQ 400MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 300MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 400MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 38 Kerry, 26 BASF, 18 Roquette, 14 Seppic, 13 Microlex e.U, 13 Gangwal Chemicals, 12 Sigachi Industries, 11 Corel Pharma Chem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 9 Actylis, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Nanjing Well Pharmaceutical, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Ingredion Pharma Solutions, 4 SPI Pharma, 4 Kima Chemical, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 4 Ulanqab Kema New Material, 4 Vasa Pharmachem, 3 The Dow Chemical Company, 2 Nomisma Healthcare, 2 Seqens, 2 Finar, 2 Clariant, 2 Jai Radhe Sales, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Qualicaps, 1 Aeon Procare, 1 DKSH, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Avesta Pharma, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

75 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 43 Disintegrants & Superdisintegrants, 37 Direct Compression, 35 Controlled & Modified Release, 29 Solubilizers, 27 Granulation, 26 Thickeners and Stabilizers, 18 Parenteral, 17 Film Formers & Plasticizers, 16 Topical, 16 Lubricants & Glidants, 15 Co-Processed Excipients, 9 Taste Masking, 9 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

27 US Medicaid Prescriptions, 450 Finished Drug Prices

MARKET PLACE

12 APIs, 10 DOSSIERS // FDF

PATENTS

14 Health Canada Patents

14 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 2 EDQM Standards, 4 USP Standards, 5 JP Standards, 29 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 57 News

POST ENQUIRY

Find the latest and updated news related to Quetiapine Hemifumarate aggregated by PharmaCompass.com.

Quetiapine Hemifumarate News Full Screen View

Quetiapine Hemifumarate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

107 Suppliers

57 USDMF

37 CEP/COS

9 JDMF

36 EU WC

33 KDMF

34 NDC API

64 Listed Suppliers

DEVELOPMENTS

13 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

31 Suppliers

DOSSIERs // Finished Dosage Forms

1260 Dossiers

192 FDA Orange Book

609 Europe

148 Canada

58 Australia

110 South Africa

143 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 100MG BASE

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 200MG BASE

TABLET;ORAL - EQ 25MG BASE

TABLET;ORAL - EQ 300MG BASE

TABLET;ORAL - EQ 400MG BASE

TABLET;ORAL - EQ 50MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 300MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 400MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

38 Kerry

26 BASF

18 Roquette

14 Seppic

13 Microlex e.U

13 Gangwal Chemicals

12 Sigachi Industries

11 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

9 Actylis

7 DFE Pharma

7 Ideal Cures Pvt Ltd

6 Lonza Capsugel

6 Nanjing Well Pharmaceutical

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Ingredion Pharma Solutions

4 SPI Pharma

4 Kima Chemical

4 Pharmatrans-Sanaq

4 Prachin Chemical

4 Ulanqab Kema New Material

4 Vasa Pharmachem

3 The Dow Chemical Company

2 Nomisma Healthcare

2 Seqens

2 Finar

2 Clariant

2 Jai Radhe Sales

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Qualicaps

Quetiapine Hemifumarate
News
Full Screen View

TABLET;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons